Page 2 - Als Progression News Today : Breaking News, Live Updates & Top Stories | Vimarsana

"We are looking at larger sample sizes to improve the accuracy and generalizability of our model, but we can use it now to inform treatment decisions."

Data from a phase 3 trial suggest high-dose vitamin D does not prevent relapse in patients with RRMS. However, at least one expert suggests the study's exclusion criteria may have been too broad.

Contrary to previous research, a new study suggests fertility treatments pose little risk of MS relapse in women who undergo fertility treatments, suggesting it may be time for new clinical guidance.

New recommendations help clinicians communicate technical information to help patients with multiple sclerosis achieve better understanding and self-care.

The first randomized trial of a disease-modifying therapy in radiological isolated syndrome, the earliest pre-clinical phase of MS, suggests dimethyl fumarate reduced the risk of a first clinical event by 80%.